NETWORK META-ANALYSIS OF TOFACITINIB VS BDMARDS OR APREMILAST FOR THE TREATMENT OF TNF INHIBITOR-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS

被引：2
|
作者：
Gladman, D. D. [1 ]
Orbai, A. -M. [2 ]
Gomez-Reino, J. [3 ]
Chang-Douglass, S. [4 ]
Leoncini, E. [4 ]
Burton, H. E. [4 ]
Kanik, K. S. [5 ]
Hendrikx, T. [6 ]
Cappelleri, J. C. [5 ]
Hsu, M. -A. [5 ]
机构：
[1] Univ Toronto, Toronto Western Hosp, Toronto, ON, Canada
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Hosp Clin Univ, Santiago De Compostela, Spain
[4] Decis Resources Grp, London, England
[5] Pfizer Inc, Groton, CT 06340 USA
[6] Pfizer Inc, Collegeville, PA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.4823
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0300
引用
收藏
页码：368 / 369
页数：2
相关论文
共 50 条
  • [1] Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis
    Gladman, Dafna D.
    Orbai, Ana-Maria
    Gomez-Reino, Juan
    Chang-Douglass, Stacey
    Leoncini, Emanuele
    Burton, Hannah E.
    Kanik, Keith S.
    Belen Romero, Ana
    Cappelleri, Joseph C.
    Hsu, Ming-Ann
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2020, 93
  • [2] COMPARISON OF THE EFFICACY AND SAFETY OF TOFACITINIB AND APREMILAST IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Lee, Young Ho
    Song, Gwan Gyu
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1275 - 1276
  • [3] Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
    Song, Gwan Gyu
    Lee, Young Ho
    [J]. CLINICAL DRUG INVESTIGATION, 2019, 39 (05) : 421 - 428
  • [4] Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
    Gwan Gyu Song
    Young Ho Lee
    [J]. Clinical Drug Investigation, 2019, 39 : 421 - 428
  • [5] Effects of bDMARDs on quality of life in patients with psoriatic arthritis: meta-analysis
    Lu, Yuqiong
    Dai, Zhanjing
    Lu, Yun
    Chang, Feng
    [J]. BMJ OPEN, 2022, 12 (04): : e058497
  • [6] Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
    Gwan Gyu Song
    Young Ho Lee
    [J]. Clinical Drug Investigation, 2019, 39 : 701 - 701
  • [7] Identification of Treatment Naive Patients with Psoriatic Arthritis Who Will Require a TNF Inhibitor
    Gromer, Dan
    Coates, Laura C.
    FitzGerald, Oliver
    Himes, Blanca
    Helliwell, Philip
    Ogdie, Alexis
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [8] Network Meta-Analysis of Targeted Immunomodulators in the Treatment of Biologic-NaiVe Psoriatic Arthritis
    Strand, Vibeke
    Husni, M. Elaine
    Singh, Rakesh
    Betts, Keith
    Song, Yan
    Griffith, Jenny
    Ganguli, Arijit
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [9] Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis: a systematic review and network meta-analysis
    P. Kawalec
    P. Holko
    P. Moćko
    A. Pilc
    [J]. Rheumatology International, 2018, 38 : 189 - 201
  • [10] EFFICACY OF RITUXIMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN MOROCCAN PATIENTS TNF ALPHA INHIBITOR-NAIVE: A PROSPECTIVE STUDY
    Watik, A.
    Rachidi, W.
    Janani, S.
    Mkinsi, O.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 878 - 878
12345